CAS RN: 508233-82-7
Vortioxetine Impurity 3
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
95% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20250525
25mg / 100mg
Out of stock
8-10 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 0.25g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 508233-82-7
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
0.25g
≥95%
0
Out of Stock
Beijing
Inquiry
508233-82-7 / 1-[2-(4-methylphenyl)sulfanylphenyl]piperazine
Standard CAS: 508233-82-7
Multi CAS: No
Basic Information
copy
CAS
508233-82-7 copy
Multi CAS
No copy
Molecular Formula
C17H20N2S copy
Molecular Weight
284.400000 copy
Exact Mass
284.134720 copy
InChI
InChI=1S/C17H20N2S/c1-14-6-8-15(9-7-14)20-17-5-3-2-4-16(17)19-12-10-18-11-13-19/h2-9,18H,10-13H2,1H3 copy
InChIKey
HAMAPMMCMQNNBY-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
20 copy
Aromatic heavy atom count
12 copy
Fraction Csp3
0.29 copy
Rotatable bonds
3 copy
H-bond acceptors
3 copy
H-bond donors
1 copy
Molar refractivity
86.83 copy
TPSA
15.27 copy
LogP / Solubility
WLOGP
3.56 copy
MLOGP
3.14 copy
XLogP3
3.8 copy
Consensus LogP
3.5 copy
Log S (ESOL)
-4.09 copy
Class (ESOL)
Slightly soluble copy
Log S (Ali)
-4.46 copy
Class (Ali)
Slightly soluble copy
Log S (SILICOS-IT)
-4.82 copy
Class (SILICOS-IT)
Slightly soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
Yes copy
CYP2C19 inhibitor
Yes copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
Yes copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-1.93 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
Yes copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
1.5 copy